HBPR 2010 Science News: Wednesday

Dear Colleagues:

The American Heart Association’s Council for High Blood Pressure and Council on the Kidney in Cardiovascular Disease are pleased to welcome you to the 64th Annual Meeting. Considered one of the most important meetings on hypertension in the world, the conference includes award and keynote lectures by outstanding scientists and clinicians, oral and poster presentations, selected from abstracts submitted by clinical and basic researchers from 20 countries, and practical workshops on focused topics.
Continue reading...

David Ellison, MD
Chair, Kidney in Cardiovascular Disease 
R. Clinton Webb, Ph.D., FAHA
Chair, High Blood Pressure Research



   Rhian M. Touyz, MD, FAHA
Program Chair, High Blood Pressure Research 2010 Scientific Sessions
“This meeting, which includes people from all over the world, Japan, Australia, Europe, Africa, and North and South America, really brings the best of the best science related to hypertension research.”

HBPR10_DavidEllison_Welcome   David Ellison, MD
Chair, Council on Kidney and Cardiovascular Disease
“This meeting is unique because it brings together experts who are interested in hypertension, but who work in different fields, including: nephrology, vascular biology, endocrinology, and neuro-sciences.”

Receptors, channels and signaling
   TRP Channels, Mechanosensors and Vascular Biology
Thomas Gudermann
Munich, Germany
Presentation slides

  Molecular Dissection of Apoptosis and Autophagy “Cross Roads” Where Life Meets Death
Lorrie A. Kirshenbaum, PhD, FAHA
Winnipeg, MB, Canada
Presentation slides

 Antihypertensive Therapies: Beyond Drugs
HBPR10_Wed_Esler   Renal Sympathetic Nerve Ablation
Murray D. Esler
Melbourne, VIC, Australia
Presentation slides

HBPR10_Wed_Brown   Immunization Against Angiotensins to Treat Hypertension
Morris J. Brown, MA, MSc, MD, FAHA
Cambridge, United Kingdom
Presentation slides

Posted by Molly AHA Science on Oct 14, 2010 3:00 PM America/Chicago

Leave a Comment

Looks like the meeting is gooing well follow the coverate on twitter #HBPR @AHAMeetings @deaconhusky has postd his poster http://twitpic.com/2xfn6b
  • Posted Thu 14 Oct 2010 12:26 PM CDT
Thanks to Molly for posting such interesting presentations. Fantastic, promising presentation “Immunization against angiotensins to treat hypertension. Type 1 hypertension (high rennin activity) responds to anti-hypertensive agents AB>CD. On the other hand type 2 hypertension (low rennin activity), Na+ dependent, responds better to CD>AB. Very much effective practical implication indeed! Vaccination is not a treatment but prevention. Although study results are not conclusive yet, vaccination against RAS may be promising in pre-hypertensive younger individuals to prevent severe hypertension. Gauranga
  • Posted Mon 18 Oct 2010 02:11 PM CDT
Gauranga, thanks (on behalf of Molly and the Science News folks) for the comment. We'll keep them coming.
  • Posted Wed 10 Nov 2010 05:17 PM CST

Log in to post a comment.